Vimentin Human

Vimentin Human Recombinant
Cat. No.
BT25715
Source
Escherichia Coli.
Synonyms
Vimentin, Vim, FLJ36605.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Purity
Greater than 95.0% as determined by:
(a) Analysis by RP-HPLC.
(b) Analysis by SDS-PAGE.
Usage

THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.

Shipped with Ice Packs
In Stock

Description

Vimentin Human Recombinant produced in E.coli cells is a single non-glycosylated protein containing 465 amino acids chain and having a molecular mass of 53.5kDa. The Vimentin is purified by proprietary chromatographic techniques.

Product Specs

Introduction
Vimentin is a type III intermediate filament protein found in mesenchymal cells. It is involved in a variety of cellular processes, including cell adhesion, migration, and signaling. Vimentin expression is often upregulated in cancer cells, and it has been implicated in tumor progression and metastasis. For example, vimentin expression in malignant glioma cells is influenced by cellular density, drug delivery methods, and chemo/radiotherapy. In detached tumor cells, vimentin and detyrosinated microtubules support the formation of extensive microtentacles, potentially facilitating metastatic spread. Overexpression of vimentin, along with activated Notch and TGFbeta signaling pathways, is observed in primary colorectal carcinomas. Furthermore, vimentin serves as a substrate for transglutaminases in arteries, and its transglutaminase-mediated dimerization offers a potential regulatory mechanism for vasodilation and remodeling. Studies have shown that inhibiting vimentin expression can hinder the migration and invasion of colon and breast cancer cell lines. As the primary intermediate filament protein in mesenchymal cells, vimentin plays a crucial role in distinguishing undifferentiated neoplasms.
Description
Recombinant Human Vimentin, expressed in E. coli, is a non-glycosylated single polypeptide chain protein. It has a molecular weight of 53.5 kDa and consists of 465 amino acids. The protein undergoes purification using proprietary chromatographic techniques.
Physical Appearance
White, sterile-filtered, lyophilized powder.
Formulation
The Vimentin protein was lyophilized from a 0.2µm filtered solution containing 30% Acetonitrile and 0.1% TFA at a high concentration.
Solubility
Reconstitute the lyophilized Vimentin in sterile 4mM HCl to a concentration of at least 100µg/ml. This solution can be further diluted in other aqueous solutions as needed.
Stability
Lyophilized Vimentin is stable at room temperature for up to 3 weeks. However, for long-term storage, it is recommended to store the lyophilized protein desiccated at a temperature below -18°C. After reconstitution, Vimentin should be stored at 4°C for 2-7 days. For future use, store at -18°C. The addition of a carrier protein like HSA or BSA (0.1%) is advised for extended storage. Avoid repeated freeze-thaw cycles.
Purity
The purity is determined to be greater than 95.0% based on the following analyses:
(a) RP-HPLC analysis.
(b) SDS-PAGE analysis.
Synonyms
Vimentin, Vim, FLJ36605.
Source
Escherichia Coli.
Amino Acid Sequence
STRSVSSSSY RRMFGGPGTA SRPSSSRSYV TTSTRTYSLG SALRPSTSRS LYASSPGGVY ATRSSAVRLR SSVPGVRLLQ DSVDFSLADA INTEFKNTRT NEKVELQELN DRFANYIDKV RFLEQQNKIL LAELEQLKGQ GKSRLGDLYE EEMRELRRQV DQLTNDKARV EVERDNLAED IMRLREKLQE EMLQREEAEN TLQSFRQDVD NASLARLDLE RKVESLQEEI AFLKKLHEEE IQELQAQIQE QHVQIDVDVS KPDLTAALRD VRQQYESVAA KNLQEAEEWY KSKFADLSEA ANRNNDALRQ AKQESTEYRR QVQSLTCEVD ALKGTNESLE RQMREMEENF AVEAANYQDT IGRLQDEIQN MKEEMARHLR EYQDLLNVKM ALDIEIATYR KLLEGEESRI SLPLPNFSSL NLRETNLDSL PLVDTHSKRT LLIKTVETRD GQVINETSQH HDDLE.

Product Science Overview

Introduction

Vimentin is a class III intermediate filament protein predominantly found in cells of mesenchymal origin, such as vascular endothelium and blood cells . It plays a crucial role in maintaining cell integrity, providing resistance against stress, and supporting cellular structure . The human Vimentin protein is encoded by the VIM gene and consists of 466 amino acids . Recombinant human Vimentin is produced using advanced biotechnological methods to ensure high purity and functionality .

Preparation Methods

Recombinant human Vimentin is typically produced in Escherichia coli (E. coli) expression systems . The gene encoding human Vimentin is cloned into an expression vector, which is then introduced into E. coli cells. These cells are cultured under optimal conditions to express the Vimentin protein. After expression, the protein is purified using affinity chromatography techniques, often involving a His-tag for easy purification . The purified protein is then lyophilized and stored under specific conditions to maintain its stability and activity .

Chemical Reactions Analysis

Vimentin is known to interact with various cellular components and participate in multiple biochemical processes. One notable interaction is with G-quadruplex (G4) structures, which are tetra-helical arrangements formed within guanine-rich tracts of DNA . Vimentin binds to these G4 structures with high affinity, potentially influencing gene expression and chromatin organization . Additionally, Vimentin plays a role in the epithelial-to-mesenchymal transition (EMT), a process critical for cancer metastasis and drug resistance . It interacts with various signaling molecules and structural proteins, contributing to cellular migration, division, and structural integrity .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.